MarketInOut Stock Screener Log In | Sign Up
 

SynBiotic SE

XETRA • Healthcare • Drug Manufacturers - Specialty & Generic • Quote as of 08/05/2026 17:35
SynBiotic SE stock price and volume chart

Company Profile

IndustryDrug Manufacturers - Specialty & Generic
SectorHealthcare
ExchangeXETRA
Market Capitalization7.3 mln
Earnings Date04/11/2025

Piotroski F-Score

2 / 9
Weak

Beneish M-Score

-1.35
Manipulation likely

Relative Strength

5 / 100
Severely lagging

Debt / Equity

0.08
Debt-free

ROE

-2.62
Negative

Dividend Yield

0.00%
No dividend

Business Description

SynBiotic SE is a Munich-based company founded in 2017 that develops and sells a range of cannabis and hemp-derived products, including dietary supplements, cosmetics, medical cannabis, and recreational cannabis goods. Its products are designed to help people manage pain, improve sleep, and reduce anxiety, and are sold under several brand names such as Hempamed, Princess Stardust, The Hempany, and Hempamed Rx. The company was previously called Ledgertech SE before adopting its current name.

Key Fundamentals

EPS-1.66
ROE-2.62
RPS0.01
ROIC-2.30
ROA-1.62
EBITDA, mln-0.45
EV / EBITDA-25.36
EV / EBIT-16.14
Revenue, mln0.07
EV / Revenue158

Financial Strength

Altman Z-Score-2.23
Piotroski F-Score 2 / 9
Beneish M-Score-1.35

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week 1.85% 60 / 100   
1 Month -10.57% 4 / 100   
2 Months -34.13% 1 / 100   
6 Months -47.12% 1 / 100   
1 Year -62.33% 1 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us